Stock listing

ACOG Stock Price, News, Filings & Events — Alpha Cognition Inc.

Selected listing: ACOG · BOATS · USD · US

This page tracks Alpha Cognition Inc.'s ACOG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACOG:BOATS. ACOG:BOATS is the stock-level entry point for investors researching Alpha Cognition Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

ACOG:BOATSUSDUSUpdated August 14, 2026
Alpha Cognition Inc. logo
Ticker
ACOG:BOATS
Asset type
Stock
Market cap
$192.5M
Sector
Finance
Industry
Financial Conglomerates
Exchange
BOATS
Currency
USD

Alpha Cognition Inc. ACOG:BOATS stock context

This page tracks Alpha Cognition Inc.'s ACOG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACOG:BOATS. ACOG:BOATS is the stock-level entry point for investors researching Alpha Cognition Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

Research Alpha Cognition Inc.

Alternate listings